Drug recall · February 12, 2025
Guaifenesin and Codeine Phosphate Oral Solution USP recall
Why: Superpotent; sodium benzoate preservative
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16
- Lots / codes
Lot number 4B07, Exp Date: 2026-OCT-31
- Quantity
- 4080 Bottles
- Company
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc, Greenville, SC
- Distribution
- OH
- Initiated
- January 7, 2025 · Voluntary: Firm initiated
- Classified
- February 4, 2025
- Reported
- February 12, 2025
- Ended
- July 25, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Codeine / guaifenesin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.